残余胆固醇在缺血性脑卒中复发中的预测价值与研究进展
The Predictive Value and Research Progress of Residual Cholesterol in Recurrent Ischemic Stroke
DOI: 10.12677/acm.2026.1641452, PDF,   
作者: 张一萌:延安大学第一临床医学院,陕西 延安;薛艺东*:延安大学第一临床医学院,陕西 延安;延安大学附属医院心脑血管医院神经内科,陕西 延安
关键词: 残余胆固醇缺血性脑卒中卒中复发动脉粥样硬化二级预防Residual Cholesterol Ischemic Stroke Stroke Recurrence Atherosclerosis Secondary Prevention
摘要: 缺血性脑卒中复发率高,严重影响患者预后及生活质量。尽管低密度脂蛋白胆固醇(LDL-C)控制已成为卒中二级预防的核心策略,但部分患者在LDL-C达标后仍存在较高复发风险,提示残余脂质风险的存在。残余胆固醇(residual cholesterol, RC)是指富含甘油三酯脂蛋白中的胆固醇成分,近年来被证实与动脉粥样硬化性心血管疾病密切相关,并逐渐受到脑血管领域关注。多项流行病学研究表明,RC水平升高与缺血性脑卒中的发生、不良功能结局及复发风险显著相关,且其预测价值可能独立于传统血脂指标。本文系统综述残余胆固醇的概念与检测方法,总结其在心脑血管疾病中的研究进展,重点分析其与缺血性脑卒中复发之间的关联及潜在机制,包括促进动脉粥样硬化进展、诱导炎症反应及增强血栓形成等作用。最后探讨其在卒中二级预防及风险分层管理中的应用前景,以期为复发风险评估及精准干预提供新的理论依据。
Abstract: The recurrence rate of ischemic stroke is high, which seriously affects the prognosis and quality of life of patients. Although low-density lipoprotein cholesterol (LDL-C) control has become a core strategy for secondary stroke prevention, some patients still have a high risk of recurrence even after LDL-C is met, indicating the existence of residual lipid risk. Residual cholesterol (RC) refers to the cholesterol component rich in triglyceride lipoproteins. In recent years, it has been confirmed that it is closely related to atherosclerotic cardiovascular disease, and has gradually attracted attention in the cerebrovascular field. Multiple epidemiological studies have shown that elevated levels of RC are significantly associated with the occurrence, adverse functional outcomes, and recurrence risk of ischemic stroke, and their predictive value may be independent of traditional lipid indicators. This article systematically reviews the concept and detection methods of residual cholesterol, summarizes its research progress in cardiovascular and cerebrovascular diseases, and focuses on the analysis of its association with the recurrence of ischemic stroke and its potential mechanisms, including promoting the progression of atherosclerosis, inducing inflammatory reaction, and enhancing the formation of blood clots. Finally, the application prospects of it in secondary prevention and risk stratification management of stroke are discussed, in order to provide new theoretical basis for recurrence risk assessment and precise intervention.
文章引用:张一萌, 薛艺东. 残余胆固醇在缺血性脑卒中复发中的预测价值与研究进展[J]. 临床医学进展, 2026, 16(4): 2070-2077. https://doi.org/10.12677/acm.2026.1641452

参考文献

[1] Ford, B., Dore, M. and Koehn, T.R. (2026) Recurrent Ischemic Stroke: Prevention Strategies. American Family Physician, 113, 57-69.
[2] Li, J., Pan, Y., Xu, J., Li, S., Wang, M., Quan, K., et al. (2021) Residual Inflammatory Risk Predicts Poor Prognosis in Acute Ischemic Stroke or Transient Ischemic Attack Patients. Stroke, 52, 2827-2836. [Google Scholar] [CrossRef] [PubMed]
[3] Pan, Y., Li, Z., Li, J., Jin, A., Lin, J., Jing, J., et al. (2021) Residual Risk and Its Risk Factors for Ischemic Stroke with Adherence to Guideline-Based Secondary Stroke Prevention. Journal of Stroke, 23, 51-60. [Google Scholar] [CrossRef] [PubMed]
[4] Li, X., Li, Z. and Wu, N. (2025) Remnant Cholesterol and Residual Risk of Atherosclerotic Cardiovascular Disease. Reviews in Cardiovascular Medicine, 26, Article No. 25985. [Google Scholar] [CrossRef] [PubMed]
[5] Feng, Q., Li, H., Zhang, R., Sun, L., Zhang, S., Chen, Y., et al. (2024) Elevated Remnant Cholesterol Is a Risk Factor for Acute Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases, 33, Article ID: 107773. [Google Scholar] [CrossRef] [PubMed]
[6] Varbo, A., Benn, M., Tybjærg-Hansen, A., Jørgensen, A.B., Frikke-Schmidt, R. and Nordestgaard, B.G. (2013) Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease. Journal of the American College of Cardiology, 61, 427-436. [Google Scholar] [CrossRef] [PubMed]
[7] Nordestgaard, B.G. (2016) Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights from Epidemiology, Genetics, and Biology. Circulation Research, 118, 547-563. [Google Scholar] [CrossRef] [PubMed]
[8] Varbo, A., Benn, M. and Nordestgaard, B.G. (2014) Remnant Cholesterol as a Cause of Ischemic Heart Disease: Evidence, Definition, Measurement, Atherogenicity, High Risk Patients, and Present and Future Treatment. Pharmacology & Therapeutics, 141, 358-367. [Google Scholar] [CrossRef] [PubMed]
[9] Burnett, J.R., Hooper, A.J. and Hegele, R.A. (2020) Remnant Cholesterol and Atherosclerotic Cardiovascular Disease Risk. Journal of the American College of Cardiology, 76, 2736-2739. [Google Scholar] [CrossRef] [PubMed]
[10] Sampson, M., Ling, C., Sun, Q., Harb, R., Ashmaig, M., Warnick, R., et al. (2020) A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients with Normolipidemia and/or Hypertriglyceridemia. JAMA Cardiology, 5, 540-548. [Google Scholar] [CrossRef] [PubMed]
[11] Wang, D., Zhang, Z., Zhang, Y., Chen, S., Qu, N., Li, H., et al. (2025) Two‐Year Changes in Remnant Cholesterol and Stroke Risk in the Chinese Population: A Prospective Cohort Study. Journal of the American Heart Association, 14, e38559. [Google Scholar] [CrossRef] [PubMed]
[12] Jiang, X., Zhuang, J., Juan, Y., Zheng, X. and Zhang, H. (2024) Association between Remnant Cholesterol and the Risk of Cardiovascular Disease in Chinese Population. Journal of Stroke and Cerebrovascular Diseases, 33, Article ID: 107825. [Google Scholar] [CrossRef] [PubMed]
[13] 刘星雨, 杜慧杰, 莫佳丽, 等. 残余胆固醇水平与缺血性脑卒中复发风险的关联性及其预测价值研究[J]. 中国全科医学, 2024, 27(26): 3227-3231.
[14] Wu, Z., Jiang, Y., Guo, Z., Li, P., Zheng, Y., Wang, Y., et al. (2024) Remnant Cholesterol Traits and Risk of Stroke: A Multivariable Mendelian Randomization Study. PNAS Nexus, 3, pgae33. [Google Scholar] [CrossRef] [PubMed]
[15] Chen, X. and Li, L. (2023) Remnant Cholesterol, a Valuable Biomarker for Assessing Arteriosclerosis and Cardiovascular Risk: A Systematic Review. Cureus, 15, e44202. [Google Scholar] [CrossRef] [PubMed]
[16] Sandesara, P.B., Virani, S.S., Fazio, S. and Shapiro, M.D. (2018) The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk. Endocrine Reviews, 40, 537-557. [Google Scholar] [CrossRef] [PubMed]
[17] Varbo, A., Benn, M., Tybjærg-Hansen, A. and Nordestgaard, B.G. (2013) Elevated Remnant Cholesterol Causes both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease without Inflammation. Circulation, 128, 1298-1309. [Google Scholar] [CrossRef] [PubMed]
[18] Duewell, P., Kono, H., Rayner, K.J., Sirois, C.M., Vladimer, G., Bauernfeind, F.G., et al. (2010) NLRP3 Inflammasomes Are Required for Atherogenesis and Activated by Cholesterol Crystals. Nature, 464, 1357-1361. [Google Scholar] [CrossRef] [PubMed]
[19] Ding, W.Y., Protty, M.B., Davies, I.G. and Lip, G.Y.H. (2021) Relationship between Lipoproteins, Thrombosis, and Atrial Fibrillation. Cardiovascular Research, 118, 716-731. [Google Scholar] [CrossRef] [PubMed]
[20] Rouland, A., Masson, D., Lagrost, L., Vergès, B., Gautier, T. and Bouillet, B. (2022) Role of Apolipoprotein C1 in Lipoprotein Metabolism, Atherosclerosis and Diabetes: A Systematic Review. Cardiovascular Diabetology, 21, Article No. 272. [Google Scholar] [CrossRef] [PubMed]
[21] Bell-Anderson, K.S. (2008) Adipokines: Linking Obesity and Cardiovascular Disease. Expert Review of Endocrinology & Metabolism, 3, 61-73. [Google Scholar] [CrossRef] [PubMed]
[22] Zhang, P., Zhang, Z., Li, D., Han, R., Li, H., Ma, J., et al. (2023) Association of Remnant Cholesterol with Intracranial Atherosclerosis in Community-Based Population: The ARIC Study. Journal of Stroke and Cerebrovascular Diseases, 32, Article ID: 107293. [Google Scholar] [CrossRef] [PubMed]
[23] Wang, A., Tian, X., Zuo, Y., Wu, J., Tang, H., Wang, Y., et al. (2021) Association of Remnant Cholesterol with Intra-and Extra-Cranial Atherosclerosis in Chinese Community Population. Atherosclerosis Plus, 46, 20-26. [Google Scholar] [CrossRef] [PubMed]
[24] Qian, S., You, S., Sun, Y., Wu, Q., Wang, X., Tang, W., et al. (2021) Remnant Cholesterol and Common Carotid Artery Intima-Media Thickness in Patients with Ischemic Stroke. Circulation: Cardiovascular Imaging, 14, e10953. [Google Scholar] [CrossRef] [PubMed]
[25] Yang, X.H., Zhang, B.L., Cheng, Y., Fu, S.K. and Jin, H.M. (2023) Association of Remnant Cholesterol with Risk of Cardiovascular Disease Events, Stroke, and Mortality: A Systemic Review and Meta-Analysis. Atherosclerosis, 371, 21-31. [Google Scholar] [CrossRef] [PubMed]
[26] Ridker, P.M. (2016) Residual Inflammatory Risk: Addressing the Obverse Side of the Atherosclerosis Prevention Coin. European Heart Journal, 37, 1720-1722. [Google Scholar] [CrossRef] [PubMed]
[27] Nordestgaard, A.T. and Nordestgaard, B.G. (2025) Remnant Cholesterol Lowering in Cardiovascular Disease Risk Reduction in Statin, Ezetimibe, and PCSK9 Inhibitor Trials: Meta-Regression Analyses. European Journal of Preventive Cardiology, zwaf337. [Google Scholar] [CrossRef] [PubMed]
[28] Pintó, X., Fanlo, M., Esteve, V. and Millán, J. (2023) Remnant Cholesterol, Vascular Risk, and Prevention of Atherosclerosis. Clínica e Investigación en Arteriosclerosis (English Edition), 35, 206-217. [Google Scholar] [CrossRef
[29] Chen, J., Wu, Q., Liu, H., Hu, W., Zhu, J., Ji, Z., et al. (2025) Predictive Value of Remnant Cholesterol Inflammatory Index for Stroke Risk: Evidence from the China Health and Retirement Longitudinal Study. Journal of Advanced Research, 76, 543-552. [Google Scholar] [CrossRef] [PubMed]
[30] Li, J., Yan, K., Zhu, P., Xu, J., Tang, X., Li, Y., et al. (2024) Association between Multiple Inflammatory Biomarkers and Remnant Cholesterol Levels in Patients with Percutaneous Coronary Intervention: A Large-Scale Real-World Study. Nutrition, Metabolism and Cardiovascular Diseases, 34, 377-386. [Google Scholar] [CrossRef] [PubMed]